Aslan Pharmaceuticals Ltd (NASDAQ:ASLN)

1.57
Delayed Data
As of 3:59pm ET
 -0.04 / -2.48%
Today’s Change
1.42
Today|||52-Week Range
6.75
-14.21%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Aslan Pharmaceuticals Ltd have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +409.55% increase from the last price of 1.57.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Aslan Pharmaceuticals Ltd. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.12
Sales
$0.00
Reporting Date
Nov 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -54.17%
 
 
 
 
 
 
Growthannually -25.00%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.